1. Structure-specific amyloid precipitation in biofluids
- Author
-
Rodrigues, M, Bhattacharjee, P, Brinkmalm, A, Do, DT, Pearson, CM, De, S, Ponjavic, A, Varela, JA, Kulenkampff, K, Baudrexel, I, Emin, D, Ruggeri, FS, Lee, JE, Carr, AR, Knowles, TPJ, Zetterberg, H, Snaddon, TN, Gandhi, S, Lee, SF, Klenerman, D, European Research Council, University of St Andrews. School of Physics and Astronomy, University of St Andrews. Centre for Biophotonics, University of St Andrews. Institute of Behavioural and Neural Sciences, Rodrigues, M [0000-0001-6364-7125], Bhattacharjee, P [0000-0002-1116-5877], Do, DT [0000-0002-5717-4285], De, S [0000-0003-1675-0773], Ponjavic, A [0000-0002-7561-1127], Varela, JA [0000-0003-1901-1378], Baudrexel, I [0000-0002-3422-8340], Ruggeri, FS [0000-0002-1232-1907], Knowles, TPJ [0000-0002-7879-0140], Snaddon, TN [0000-0003-1119-0332], Gandhi, S [0000-0003-4395-2661], Lee, SF [0000-0003-4492-5139], Klenerman, D [0000-0001-7116-6954], and Apollo - University of Cambridge Repository
- Subjects
MCC ,Amyloid ,Bodily Secretions ,Amyloid beta-Peptides ,General Chemical Engineering ,education ,Organic Chemistry ,DAS ,General Chemistry ,QD Chemistry ,Organische Chemie ,AC ,Protein Aggregates ,SDG 3 - Good Health and Well-being ,RC0321 ,Life Science ,Humans ,QD ,RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry ,Physical Chemistry and Soft Matter - Abstract
Funding: This work was supported by the National Institute of Health Research University College London Hospitals Biomedical Research Centre. SG is an MRC Senior Clinical Fellow (MR/T008199/1). H.Z. is a Wallenberg Scholar supported by grants from the Swedish Research Council (no. 2018-02532), the European Research Council (no. 681712), Swedish State Support for Clinical Research (no. ALFGBG-720931) and the UK Dementia Research Institute at University College London (UCL). D.K. is supported by grants from the European Research Council (no. 669237), the Royal Society and the UK Dementia Research Institute at Cambridge. We thank the Royal Society for the University Research Fellowship to S.F.L. (UF120277), and T.N.S. thanks the National Institutes of Health (R01GM121573). Also, we are thankful for the Michael J. Fox Grant to S.F.L. and T.N.S. (grant no. 10200). J.A.V. is supported by the European Research Council with an ERC Starting Grant (no. 804581). The composition of soluble toxic protein aggregates formed in vivo is currently unknown in neurodegenerative diseases, due to their ultra-low concentration in human biofluids and their high degree of heterogeneity. Here we report a method to capture amyloid-containing aggregates in human biofluids in an unbiased way, a process we name amyloid precipitation. We use a structure-specific chemical dimer, a Y-shaped, bio-inspired small molecule with two capture groups, for amyloid precipitation to increase affinity. Our capture molecule for amyloid precipitation (CAP-1) consists of a derivative of Pittsburgh Compound B (dimer) to target the cross β-sheets of amyloids and a biotin moiety for surface immobilization. By coupling CAP-1 to magnetic beads, we demonstrate that we can target the amyloid structure of all protein aggregates present in human cerebrospinal fluid, isolate them for analysis and then characterize them using single-molecule fluorescence imaging and mass spectrometry. Amyloid precipitation enables unbiased determination of the molecular composition and structural features of the in vivo aggregates formed in neurodegenerative diseases. Postprint
- Published
- 2022